Executive Board

Robert E. Dudley, Ph.D. Frank Jaeger Chairman, Chief Executive Chief Commercial Officer Officer and President As a veteran marketer in the men’s Robert E. Dudley, Ph.D., has devoted health field, Frank Jaeger has built his career to developing products that his career by fostering productive revolutionize healthcare for men. As conversations between physicians and the co-inventor of multiple formulations consumers and encouraging men to of testosterone replacement therapies, speak to their doctors about sensitive he is a leading voice in hypogonadism and men’s health. health issues. He joined Clarus Therapeutics, Inc. in September 2019 as Chief Commercial Officer—bringing over 20 years of Driven by a mission to help men overcome the symptoms of sales, marketing and business development experience in the hypogonadism, Dr. Dudley established Clarus Therapeutics, Inc. healthcare industry. He has a strong record of accomplishments in 2004, and has served as , President, and in men’s health, including launching and managing Abbott’s Chairman of the since its founding. Prior to market-leading treatment for low testosterone. founding Clarus Therapeutics, Dr. Dudley served as the President, Chief Executive Officer and Director of Anagen Therapeutics. He Before joining Clarus Therapeutics, Mr. Jaeger served as Regional also held senior executive positions at Unimed Pharmaceuticals. Sales Director of the West Region, Metabolic Division, and as Director of Men’s Health Marketing, Metabolic Division at AbbVie. Dr. Dudley has more than 25 years of experience in the testosterone replacement therapy field. Most notably, he led the Mr. Jaeger holds a Bachelor of Arts and Master of Arts discovery, development, regulatory approval and launch of the in psychology from the University of Illinois, Chicago first testosterone gel product, which became the market leader. and a Master of Business Administration from the Lake Forest Graduate School of . Dr. Dudley received his Bachelor of Science in biology from Pepperdine University, Seaver College, his Master of Science in biology from the University of New Jay Newmark, M.D., MBA Mexico and his Ph.D., with honors, in Pharmacology and Toxicology from the University of Kansas School of With extensive experience in both private Medicine. He is also a board-certified toxicologist. urology practice and commercial product development, Jay Newmark was already Steven A. Bourne, CPA a leading voice in men’s health when , he joined Clarus Therapeutics, Inc. in Secretary and Treasurer December 2019 as Chief Medical Officer. Following 16 years as Steven A. Bourne, CPA, is a finance a urologist in private practice, he worked to develop advanced and accounting professional with a detection technologies for prostate cancer as Senior Director passion for working with innovative, of Medical Affairs at Genomic Health and OPKO Health. He has early-stage life science companies. worked closely with commercial development He joined Clarus Therapeutics, Inc. and academic researchers to design clinical trial protocols and in February 2004, and currently serves as Chief Financial co-author publications on topics in oncology and urology. Officer, Secretary and Treasurer. His career has spanned Dr. Newmark received his M.D. from the University of Michigan more than two and a half decades, amassing deep financial Medical School and completed his residency in urology leadership expertise for specialty pharmaceutical, biotech at the Johns Hopkins Hospital. He also holds a Master of and medical device companies. Prior to Clarus Therapeutics, Business Administration from the University of Chicago. he served as Chief Financial Officer, Secretary and Treasurer at Anagen Therapeutics, and Treasurer, Secretary and Controller at Aksys, a public medical device company.

Mr. Bourne holds a Bachelor of Science in accounting from Miami University and is a Certified Public Accountant.

COR-US-0001 01/2020 Executive Board

James Holloway LaTonya Wright , Manufacturing Vice President, Sales and Supply LaTonya Wright is a proven leader whose James Holloway joined Clarus teams consistently exceed ambitious Therapeutics, Inc. in October 2019 as sales targets. She joined Clarus Vice President, Manufacturing and Therapeutics, Inc. in October 2019 as Vice Supply with extensive experience in President, Sales with more than 20 years pharmaceutical manufacturing operations. His background of healthcare experience gained through includes roles of increasing responsibility at DSM roles at Amgen, Abbott and AbbVie. Under her leadership as Pharmaceuticals, Cardinal Health, Pfizer and Boehringer Regional Sales Director at AbbVie, her team won national awards Ingelheim. Prior to Clarus Therapeutics, he led the research for sales and performance. Previously, she launched another and development project management office of the Infection TRT treatment with an innovative go-to-market model. At Clarus Prevention franchise of CareFusion (now BD Medical), where he Therapeutics, Ms. Wright is in charge of building and leading increased revenue and improved on-time delivery. Mr. Holloway the sales by developing sales, market access, and has launched more than 55 drugs and biologic products. operational strategies.

Mr. Holloway holds a Bachelor of Science and a Master of Ms. Wright holds a Bachelor of Arts from Michigan State Science from Fisk University. University. She served in the United States Army, reaching the rank of Staff Sergeant.

COR-US-0001 01/2020